Editorial: Immunology of cachexia

Editorial: Immunology of cachexia

Bibliographic Details
Main Authors:	Vijay Kumar, John H. Stewart
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Immunology
Subjects:	cachexia immunity inflammation NLRP3 inflammasome cancer immune-checkpoint inhibitors
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1339263/full

Similar Items

Cachexia causes time‐dependent activation of the inflammasome in the liver
by: Rodrigo Xavier dasNeves, et al.
Published: (2023-08-01)

Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia
by: Trang T. Vu, et al.
Published: (2024-01-01)

Weight and Blood‐Based Markers of Cachexia Predict Disability, Hospitalization and Worse Survival in Cancer Immunotherapy Patients
by: Steven D. Tran, et al.
Published: (2025-02-01)

Fantastic voyage: The journey of NLRP3 inflammasome activation
by: Xiangyong Que, et al.
Published: (2024-03-01)

Immunoregulation in cancer-associated cachexia
by: Qi Wu, et al.
Published: (2024-04-01)

Editorial: Inflammasomes in human diseases and metabolism
by: Gabriel Mbalaviele, et al.
Published: (2024-05-01)

Gut microbiota: a novel target for exercise-mediated regulation of NLRP3 inflammasome activation
by: Jun Chen, et al.
Published: (2025-01-01)

The non-pathogenic protozoon Leishmania tarentolae interferes with the activation of NLRP3 inflammasome in human cells: new perspectives in the control of inflammation
by: Francesca La Rosa, et al.
Published: (2024-04-01)

Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy
by: Hayato Kawachi, et al.
Published: (2025-12-01)

Research progress on NLRP3 inflammasomes in male reproductive immunity
by: Xue Zhang, et al.
Published: (2024-08-01)

NLRP3 and Gut Microbiota Homeostasis: Progress in Research
by: Hongming Pan, et al.
Published: (2022-11-01)

Mechanism behind the Upregulation of Proteins Associated with the NLRP3 Inflammasome in Periodontitis and Their Role in the Immune Response in Diabetes—A Systematic Review
by: Elisabetta Ferrara, et al.
Published: (2023-07-01)

Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment
by: Panagiotis Theofilis, et al.
Published: (2023-08-01)

R‐ketorolac ameliorates cancer‐associated cachexia and prolongs survival of tumour‐bearing mice
by: Sophia E. Chrysostomou, et al.
Published: (2024-04-01)

Role of NLRP3 inflammasome in central nervous system diseases
by: Lu Zhang, et al.
Published: (2024-06-01)

Peripheral-central network analysis of cancer cachexia status accompanied by the polarization of hypothalamic microglia with low expression of inhibitory immune checkpoint receptors
by: Yukari Suda, et al.
Published: (2024-04-01)

Inflammasomes cross-talk with lymphocytes to connect the innate and adaptive immune response
by: Hongliang Zhang, et al.
Published: (2023-12-01)

Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models
by: Biswadeep Das, et al.
Published: (2021-08-01)

Indoxyl Sulfate Mediates the Low Inducibility of the NLRP3 Inflammasome in Hemodialysis Patients
by: Li-Chun Ho, et al.
Published: (2021-01-01)

Mycotoxin Zearalenone Attenuates Innate Immune Responses and Suppresses NLRP3 Inflammasome Activation in LPS-Activated Macrophages
by: Po-Yen Lee, et al.
Published: (2021-08-01)

Physical exercise at the crossroad between muscle wasting and the immune system: implications for lung cancer cachexia
by: Francesco Cortiula, et al.
Published: (2022-02-01)

Cancer cachexia: biomarkers and the influence of age
by: Julia Geppert, et al.
Published: (2024-09-01)

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
by: Zhuo Liu, et al.
Published: (2025-01-01)

The Effects of Divalent Cation-Chelated Prion Fibrils on the Immune Response of EOC 13.31 Microglia Cells
by: Huan-I Jen, et al.
Published: (2020-10-01)

Palmitic acid activates NLRP3 inflammasome and induces placental inflammation during pregnancy in mice
by: Michiya SANO, et al.
Published: (2020-02-01)

Research advances in the regulatory mechanisms of NLRP3 inflammasome activation
by: Liu Feng, et al.
Published: (2024-06-01)

Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis
by: Harsh Vardhan Charan, et al.
Published: (2023-03-01)

CARD8: A Novel Inflammasome Sensor with Well-Known Anti-Inflammatory and Anti-Apoptotic Activity
by: Tugay Karakaya, et al.
Published: (2024-06-01)

Understanding the Role of NLRP3 Inflammasome in Acute Pancreatitis
by: Konstantinos Papantoniou, et al.
Published: (2024-11-01)

The Novel Role of the NLRP3 Inflammasome in Mycotoxin-Induced Toxicological Mechanisms
by: Chengshui Liao, et al.
Published: (2024-06-01)

Progress on the role of NLRP3 inflammasome in hyperuricemic nephropathy
by: DAI Zhixin, WANG Yumin
Published: (2023-02-01)

Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer
by: Hailun Xie, et al.
Published: (2023-02-01)

Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
by: Leo R. Brown, et al.
Published: (2024-06-01)

Molecular Mechanisms of Inflammasome in Ischemic Stroke Pathogenesis
by: Maria Grazia Puleo, et al.
Published: (2022-09-01)

NLRP3 inflammasome in cardiovascular diseases: an update
by: Binhai Mo, et al.
Published: (2025-02-01)

The Role of the NLRP3 Inflammasome in the Molecular and Biochemical Mechanisms of Cervical Ripening: A Comprehensive Review
by: Wojciech Flis, et al.
Published: (2024-03-01)

NLRP3 exacerbates EAE severity through ROS-dependent NET formation in the mouse brain
by: Da Jeong Byun, et al.
Published: (2024-02-01)

Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation
by: Chi-Han Huang, et al.
Published: (2021-06-01)

The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging
by: Allison K. Meyers, et al.
Published: (2020-07-01)

NLPR3 Inflammasomes and Their Significance for Atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2020-07-01)